Play games to treat ADHD digital therapy cutting-edge to obtain 160 million US dollars in financing

Akili Interactive is developing a video game that has been clinically proven to improve cognitive functions.
It has recently announced that it has completed a US$160 million financing, including a US$110 million Series D financing
.

D round of financing led by the investment Neuberger Berman Funds, more than a dozen other investors also participated in this round of financing, including Amgen Ventures, Polaris Partners, M Ventures and so on

Akili will use the new funds to help commercialize its EndeavorRx, while Akili will develop other treatments for acute and chronic cognitive impairment based on video games
.

EndeavorRx can be used in conjunction with drugs and other ADHD therapies to improve the attention function of children 8 to 12 years old

It has been clinically proven that they can target the brain regions responsible for attention
.

The game requires children to navigate the animated character of their choice on a road full of obstacles, avoid dangerous areas, and collect targets at the same time

In randomized clinical trials, about half of the parents of children participating in the study reported that their children’s ADHD symptoms had improved, and nearly 60% of children said EndeavorRx can improve their concentration
.

In another unblinded study, nearly 70% of parents saw their children's ADHD-related disorders improve after their children played for two months

Akili CEO Eddie Martucci said in a statement that the company aims to make digital therapy a more feasible and accessible treatment option for more people
.

Mr.
Martucci said: “In addition to treating diseases, future digital therapies will also have richer data that can adapt to the unique needs and preferences of each user, provide amazing experiences, and even integrate into our daily lives

Reference materials:

[1] Prescription video game developer Akili snags $160M to launch ADHD treatment.

Retrieved 2021-05-27, from https://